Endurant Capital Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,870
| Closed | -$859K | – | 9 |
|
|
2023
Q4 | $859K | Buy |
+12,870
| New | +$834K | 4.92% | 7 |
|
|
2023
Q3 | – | Sell |
-32,710
| Closed | -$2.21M | – | 50 |
|
|
2023
Q2 | $2.21M | Buy |
32,710
+6,239
| +24% | +$391K | 1.93% | 17 |
|
|
2023
Q1 | $1.43M | Sell |
26,471
-51,673
| -66% | -$3.01M | 0.74% | 33 |
|
|
2022
Q4 | $4.67M | Sell |
78,144
-4,785
| -6% | -$260K | 1.9% | 15 |
|
|
2022
Q3 | $3.75M | Buy |
+82,929
| New | +$4.15M | 1.22% | 23 |
|
|
2022
Q2 | – | Sell |
-82,526
| Closed | -$4.67M | – | 61 |
|
|
2022
Q1 | $4.67M | Buy |
+82,526
| New | +$4.31M | 1.23% | 21 |
|
|
2021
Q2 | – | Sell |
-168,188
| Closed | -$11M | – | 69 |
|
|
2021
Q1 | $11M | Buy |
168,188
+76,296
| +83% | +$4.98M | 2.86% | 13 |
|
|
2020
Q4 | $6.04M | Sell |
91,892
-255,172
| -74% | -$15M | 2.18% | 16 |
|
|
2020
Q3 | $17.9M | Buy |
347,064
+169,582
| +96% | +$8.7M | 5.31% | 4 |
|
|
2020
Q2 | $8.74M | Buy |
177,482
+107,575
| +154% | +$5.8M | 0.48% | 10 |
|
|
2020
Q1 | $3.56M | Sell |
69,907
-135,100
| -66% | -$7.79M | 1.61% | 16 |
|
|
2019
Q4 | $11.3M | Buy |
205,007
+190,059
| +1,271% | +$10.3M | 3.56% | 9 |
|
|
2019
Q3 | $753K | Sell |
14,948
-129,357
| -90% | -$6.5M | 0.27% | 41 |
|
|
2019
Q2 | $7.27M | Buy |
+144,305
| New | +$7M | 2.87% | 14 |
|
|
2019
Q1 | – | Sell |
-107,187
| Closed | -$5.26M | – | 75 |
|
|
2018
Q4 | $5.26M | Buy |
+107,187
| New | +$6.1M | 2.78% | 16 |
|
|
2017
Q4 | – | Sell |
-27,408
| Closed | -$1.01M | – | 79 |
|
|
2017
Q3 | $1.01M | Sell |
27,408
-12,318
| -31% | -$439K | 0.31% | 69 |
|
|
2017
Q2 | $1.53M | Sell |
39,726
-98,549
| -71% | -$3.61M | 0.43% | 55 |
|
|
2017
Q1 | $4.71M | Sell |
138,275
-162,656
| -54% | -$5.34M | 1.51% | 26 |
|
|
2016
Q4 | $9.87M | Sell |
300,931
-4,148
| -1% | -$135K | 4.08% | 2 |
|
|
2016
Q3 | $9.85M | Sell |
305,079
-155,628
| -34% | -$5.04M | 3.65% | 5 |
|
|
2016
Q2 | $14.2M | Buy |
460,707
+909
| +0.2% | +$28.4K | 4.76% | 4 |
|
|
2016
Q1 | $13.8M | Buy |
459,798
+1,885
| +0.4% | +$52K | 4.46% | 3 |
|
|
2015
Q4 | $12.7M | Buy |
457,913
+305,439
| +200% | +$8.69M | 4.24% | 4 |
|
|
2015
Q3 | $4.65M | Buy |
+152,474
| New | +$5.31M | 1.55% | 22 |
|
|
2015
Q2 | – | Sell |
-88,479
| Closed | -$3.12M | – | 98 |
|
|
2015
Q1 | $3.12M | Sell |
88,479
-207,844
| -70% | -$7.11M | 1.03% | 37 |
|
|
2014
Q4 | $9.07M | Buy |
+296,323
| New | +$9.24M | 3.56% | 7 |
|
Other funds holding EHC
Endurant Capital Management's EHC Position: Q1 2024 in Review
Endurant Capital Management sold out of Encompass Health (EHC) in Q1 2024, closing a stake of 12,870 shares — an estimated $859K sold.
Endurant Capital Management first reported a position in EHC in Q4 2014 and held it in 26 quarters. The position peaked at $17.9M in Q3 2020. 438 funds tracked by Wall St. Rank hold EHC as of Q1 2024.
- Endurant Capital Management reported no remaining Encompass Health position as of Q1 2024 after selling out during the quarter.
- Endurant Capital Management sold 12,870 Encompass Health shares in Q1 2024, an estimated $859K.
- Endurant Capital Management first reported a position in Encompass Health in Q4 2014 and held it in 26 quarters.
- Endurant Capital Management's Encompass Health position peaked at $17.9M in Q3 2020.
- 438 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.
Based on Endurant Capital Management's 13F filing for Q1 2024.